Rafael Carrera, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 201 S Hiawatha Ave, Pipestone, MN 56164 Phone: 507-280-0694 |
News Archive
A large-scale malaria prevention program through which medical aid group Medecins Sans Frontieres (MSF) gave intermittent doses of anti-malaria drugs to 175,000 children in Mali and Chad suggests that "widely distributing anti-malaria drugs to healthy children in African countries can significantly reduce the number of new cases of the disease," VOA News reports.
A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the U.S. Food and Drug Administration, a remarkable accomplishment in new drug development.
The 2014/2015 Ebola outbreak in West Africa shone the spotlight not only on the unpreparedness of local health services and science to deal with the pandemic, but also on the phenomenon of emerging infectious diseases (EIDs).
The development of drugs for brain-related conditions is not an efficient process; only 8% of candidate drugs that enter clinical trials gain FDA approval. A key reason for this low success rate is a lack of preclinical tests that accurately predict drug efficacy and detect unwanted side effects.
The field of heart failure in pediatric populations has recently initiated more registries and clinical trials. This age group has special concerns and particularities regarding their clinical picture and management. Therefore, multiple disciplines have been involved in the management of heart failure in this age group.
› Verified 5 days ago